IDH1/2 mutation is associated with seizure as an initial symptom in low-grade glioma: A report of 311 Chinese adult glioma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IDH1/2 mutation is associated with seizure as an initial symptom in low-grade glioma: A report of 311 Chinese adult glioma patients

Published:2015-01 Issue: Volume:109 Page:100-105
ISSN:0920-1211
Container-title:Epilepsy Research
language:en
Short-container-title:Epilepsy Research

Author:

Zhong Zhang,Wang Zheng,Wang Yinyan,You Gan,Jiang Tao

Funder

National High Technology Research and Development Program of China

National Natural Science Foundation of China

International Science and Technology Cooperative Program

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference15 articles.

1. Detection of 2-hydroxyglutaratein IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy;Andronesi;Sci. Transl. Med.,2012

2. Analysis of the IDH1 codon 132 mutation in brain tumors;Balss;Acta Neuropathol.,2008

3. Elevated serum S-100B levels in children with temporal lobe epilepsy;Calik;Seizure,2013

4. Seizure characteristics and control following resection in 332 patients with low-grade gliomas;Chang;J. Neurosurg.,2008

5. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate;Dang;Nature,2010

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi‐omics technologies and molecular biomarkers in brain tumor‐related epilepsy;CNS Neuroscience & Therapeutics;2024-04

2. Concurrent glioma and multiple sclerosis: A systematic review of case reports;Multiple Sclerosis and Related Disorders;2024-04

3. A pan-cancer analysis has uncovered CCDC58, a mitochondrial gene associated with epilepsy, as a potential prognostic and immunotherapeutic biomarker for various cancer types, including gliomas;2024-02-02

4. IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults;Pathology - Research and Practice;2024-02

5. Motor dysfunction as a primary symptom predicts poor outcome: multicenter study of glioma symptoms;Frontiers in Oncology;2024-01-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3